Research output per year
Research output per year
-
Adjuvante Therapie des Kolonkarzinoms im Umbruch
Piringer, G., 01 Sept 2025, Springer Medizin.Research output: Other contribution
-
ASCO highlights: neoadjuvant immunotherapy in mismatch repair deficient colorectal cancer
Piringer, G., 31 Jan 2025, In: memo - Magazine of European Medical Oncology. 18, 1, p. 26-29 4 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Biomarkerdiagnostik bei Karzinomen des oberen Gastrointestinaltrakts
Translated title of the contribution :Biomarker testing for carcinomas of the upper gastrointestinal tract Research output: Contribution to journal › Review article › peer-review
Open Access -
Neoadjuvant therapies ready to cure? A focus on MSS and MSI-h colon and rectal cancer
Piringer, G., 11 Nov 2025, In: memo - Magazine of European Medical Oncology. 18, 4, p. 294-297 4 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial
Dong, Y., Santol, J., Grünberger, B., Lenauer, A., Thaler, J., Piringer, G. & et al., Feb 2024, In: Cancers. 16, 5, p. 857 14 p., 857.Research output: Contribution to journal › Article › peer-review
Open Access
-
A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Parallel-Arm Study Followed by an Open-Label Arm to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia (ARGX-113-2402)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Solomianyi, O. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
04.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Phase III randomized, open-label, international, multicenter study evaluating the efficacy and safety of mosunetuzumab plus lenalidomide in comparison to anti- CD20 monoclonal antibody plus chemotherapy in subjects with previously untreated FLIPI 2-5 follicular lymphoma (MorningLyte)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Solomianyi, O. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
02.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
AGMT Metastasic Colorectal Cancer Registry (mCRC) Third Line and Beyond (mCRC Registry)
Krivic, D. (Researcher), Piringer, G. (PI), Lichtenauer, N. (Researcher), Schmitt, C. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Solomianyi, O. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
20.12.2024 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
-
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery (MK-2870-012)
Krivic, D. (Researcher), Preuß, C. I. (PI), Schwarz, H. K. (Researcher), Schmitt, C. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Solomianyi, O. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher), Trathnigg, N. (Researcher) & Lichtenauer, N. (Researcher)
18.12.2024 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Circulating tumor DNA based decision for adjuvant treatment in colon cancer stage II evaluation
Ghanem, R. (Researcher), Kausche, L. E. (Researcher), Klein, K. (Researcher), Kovacsova, J. (Researcher), Krenosz, K. J. (Researcher), Krivic, D. (Researcher), Kühr, T. (Researcher), Popp, H. D. (Researcher), Schmitt, C. (Researcher), Schneeweiß, B. (Researcher), Schwarz, H. (Researcher), Solomianyi, O. (Researcher), Stegemann, M. (Researcher) & Piringer, G. (PI)
12.11.2024 → 31.12.2027
Project: Clinical studies › Clinical Study (Industry project)
-
Kolorektalkarzinom – later lines
Piringer, G. (Speaker)
02 Dec 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Vorsitz: Gastrointestinal Tumore
Piringer, G. (Contributor)
20 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
“Digital Twins” in Oncology: A Proof-of-Concept for Predicting CRC Therapy Outcomes through Proximity Matching
Piringer, G. (Speaker)
13 Nov 2025Activity: Talk or presentation › Poster presentation › science-to-science
-
Onkologie – Therapieupdates & Kongresshighlights
Piringer, G. (Speaker)
11 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
ABCSG-Colorectal Branch, Vorsitz, CHALLENGE & EXERCISE – Sport als Therapeutikum
Piringer, G. (Speaker)
08 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
Prizes
-
Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer
Piringer, G. (Recipient), 16 May 2024
Prize: Prize, award or honor